EI
ACIU icon

EFG International’s AC Immune ACIU Stock Holding History

EFG International’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.2K Sell
9,900
-3,000
-23% -$9.32K ﹤0.01% 797
2025
Q4 		$40.5K Buy
+12,900
New +$40.7K ﹤0.01% 694

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

EFG International's ACIU Position: Q1 2026 in Review

EFG International reduced its AC Immune (ACIU) stake by 23% in Q1 2026, selling an estimated $9.32K and leaving 9,900 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #797.

EFG International first reported a position in ACIU in Q4 2025 and has held it in 2 quarters since. The position peaked at $40.5K in Q4 2025. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • EFG International held 9,900 shares of AC Immune worth $27.2K as of Q1 2026.
  • EFG International sold 3,000 AC Immune shares in Q1 2026, an estimated $9.32K.
  • AC Immune made up ﹤0.01% of EFG International's portfolio in Q1 2026, its #797 holding.
  • EFG International first reported a position in AC Immune in Q4 2025 and has held it in 2 quarters since.
  • EFG International's AC Immune position peaked at $40.5K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on EFG International's 13F filing for Q1 2026, filed 15 May 2026.